Invokana came out into the market and approved by the FDA in 2013 as part of a new drug to help people with type 2 diabetes. Johnson & Johnson’s new drug causes the blood sugar to leave the body through the urine, but what can happen as a result of the blood sugar going through the urine, the body will start produce too many acids called ketones, and turn into a condition otherwise known as ketoacidosis.
Ketones, is a condition, in which the body burns fat for energy. Your body normally gets the energy it needs from carbohydrates, but because the ketones are now taking the fat from your body, the risks of hospitalization increases. Plenty of the symptoms that can arise from taking Invokana include nausea, vomiting, difficulty breathing, confusion, abdominal pain, fatigue, or sleepiness. Many people who have stated that their symptoms arose after only two weeks of being on the medication. But because there are more people than ever before that are being diagnosed with type 2 diabetes, and Johnson & Johnson are profiting from everyone that is taking the drug to treat their type 2 diabetes.
Invokana was approved by the FDA in 2013, and since then the company has been pushing the advertisement and usage for the drug since its release. Due to this, Johnson & Johnson has spent over $7 million to pay doctors to push the drug into the market. And on top of the $7 million, $16 million was spent to advertise in medical journals. With aggressive advertisement, Invokana has become the number one selling drug for type 2 diabetes. But it was not until 2015 that the FDA issued a warning about Invokana, or SGLT2 Inhibitors. Also in the same year, the Institute for Safe Medication Practices, reported about the number of reactions to the drug that people were having due to Invokana.
The report included 54 cases of kidney failure or impairment, 54 cases of severe dehydration or fluid imbalance, 11 cases of kidney stones, 50 cases of urinary tract infections, and 52 cases of abnormal weight loss. And before the FDA approved the drug, animal studies found that longterm exposure to Invokana could lead to having longterm kidney damage, testicular/kidney cancers, and abnormalities in the bones.